Prof. Dr. Mohammad Amjad Kamal is a distinguished scientist affiliated with the Department of Pharmaceutical Sciences, Princess Nourah bint Abdulrahman University, Saudi Arabia, where he leads a global research team. His extensive contributions to biochemistry research have resulted in over 700 publications in internationally renowned journals. Notably, his work played a pivotal role in the development of novel anti-Alzheimer agents, transitioning them from the laboratory to clinical trials in collaboration with Dr. Nigel H. Greig, Chief of the Laboratory of Neurosciences at NIH in the USA. Recently, he has been serving the Academy of Bioelectric Meridian Massage Australia (ABMMA) as the head of the research department in establishing the therapeutic potential of Bioelectric Meridian Therapy (BMT) in supporting human health across all life stages. He has been recognised as a highly cited researcher by Clarivate in the last two consecutive years as well.